デフォルト表紙
市場調査レポート
商品コード
1363294

人工臓器とバイオニクスの市場規模、シェア、動向分析レポート:製品別、技術別、地域別、セグメント予測、2023年~2030年

Artificial Organs And Bionics Market Size, Share & Trends Analysis Report By Product (Artificial Organ, Artificial Bionics), By Technology (Mechanical, Electronic), By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 110 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
人工臓器とバイオニクスの市場規模、シェア、動向分析レポート:製品別、技術別、地域別、セグメント予測、2023年~2030年
出版日: 2023年09月26日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

人工臓器とバイオニクス市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の人工臓器とバイオニクス市場規模は2030年までに700億9,000万米ドルに達し、予測期間中にCAGR9.3%で拡大すると予測されています。

臓器不全の有病率の増加により、人造臓器やバイオニクス装置の使用が大幅に増加しています。腎臓、心臓、肺、肝臓、膵臓を移植するドナーに対する需要の高まりは、市場成長を後押しする主要因です。さらに、多くのバイオテクノロジー企業や医療機器企業が、3Dプリンターによるバイオニクスの開発に注力しています。これらのデバイスは、筋電技術や感覚電気技術を利用しており、人体の人工パーツの可動性を可能にしています。

COVID-19パンデミックは、人工臓器とバイオニクス市場に悪影響を及ぼしました。機能障害や臓器不全を抱える患者は、パンデミックによってさらなる課題に直面しました。社会的な距離のため、多くの医療施設は非選択的な処置や手術に制限され、代わりに市場成長の限界を克服するために、障害を持つ患者にビデオ会議を提供しました。さらに、市場の成長を妨げている治療の限界もあります。

製品上市の増加とFDAによるこれらの装置の迅速な承認が、ドナー不足を解消しています。人工人体部品の研究開発の高まりも、人工臓器とバイオニクス市場の成長を後押ししています。例えば、2022年3月31日、Edwards Lifesciences社は、心臓の僧帽弁位置に特化して設計されたMITRIS RESILIA弁(組織弁置換)をFDAが認証したことを確認しました。このように、ヘルスケア支出の増加とFDAによる人工人体部品の迅速な承認により、市場は予測期間中に堅調な成長が見込まれます。

人工臓器とバイオニクス市場レポート・ハイライト

  • 人工臓器分野は、移植手術件数の増加により、2022年には他のすべての分野の中で最も多くの収益を生み出しました。バイオニクス分野も、製品の進歩により最も高いCAGRが見込まれています。
  • 腎臓分野は、腎不全の増加により、2022年に約57.3%の最大市場シェアを占めました。
  • 人工内耳分野は、老年人口の増加により、最も高い成長率を記録すると予想されています。
  • 北米は2022年の地域別セグメントでトップであり、高度なヘルスケア施設の存在により予測期間中もその地位を維持すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 人工臓器とバイオニクス市場の変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 人工臓器とバイオニクス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 人工臓器とバイオニクス:製品別推定・動向分析

  • 人工臓器とバイオニクス市場:重要なポイント
  • 人工臓器とバイオニクス市場:動向および市場シェア分析、2022年および2030年
  • 人工臓器
    • 人工臓器市場推計・予測、2018年から2030年まで
    • 腎臓
    • 心臓
    • 肝臓
    • 膵臓
  • 人工バイオニクス
    • 人工バイオニクス市場推計・予測、2018年から2030年まで
    • 人工内耳
    • 外骨格
    • バイオニック手足
    • 視覚の手足
    • ブレインバイオニクス

第5章 人工臓器とバイオニクス:技術別推定・動向分析

  • 人工臓器とバイオニクス市場:重要なポイント
  • 人工臓器とバイオニクス市場:動向および市場シェア分析、2022年および2030年
  • 機械式
  • 電子

第6章 人工臓器とバイオニクス市場:地域別推定・動向分析

  • 地域別の展望
  • 地域別の人工臓器とバイオニクス市場:重要なポイント
  • 北米
    • 市場推計・予測、2018~2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • ABIOMED
    • Berlin Heart
    • Zimmer Biomet
    • Boston Scientific Corporation
    • Cochlear Ltd.
    • Edwards Lifesciences Corporation
    • Ekso Bionics
    • Medtronic
    • Jarvik Heart, Inc
    • SynCardia Systems, LLC
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America artificial organ and bionics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 7 Canada artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 9 Europe artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Europe artificial organ and bionics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 UK artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 16 France artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 17 France artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Italy artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Spain artificial organ and bionics market, byproduct, 2018 - 2030 (USD Million)
  • Table 21 Spain artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Sweden artificial organ and bionics market, byproduct, 2018 - 2030 (USD Million)
  • Table 23 Sweden artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Norway artificial organ and bionics market, byproduct, 2018 - 2030 (USD Million)
  • Table 25 Norway artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Denmark artificial organ and bionics market, byproduct, 2018 - 2030 (USD Million)
  • Table 27 Denmark artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific artificial organ and bionics market, byproduct, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific artificial organ and bionics market, by region, 2018 - 2030 (USD Million)
  • Table 31 China artificial organ and bionics market, byproduct, 2018 - 2030 (USD Million)
  • Table 32 China artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Japan artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 34 Japan artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 35 India artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 36 India artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 37 Australia artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Thailand artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 41 South Korea artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Latin America artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Latin America artificial organ and bionics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Mexico artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Argentina artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa artificial organ and bionics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 59 UAE artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Kuwait artificial organ and bionics market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait artificial organ and bionics market, by technology, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Artificial organ and bionics: Market outlook
  • Fig. 9 Artificial organ and bionics: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Artificial organ and bionics market driver impact
  • Fig. 15 Artificial organ and bionics market restraint impact
  • Fig. 16 Artificial organ and bionics market strategic initiatives analysis
  • Fig. 17 Artificial organ and bionics market: Product movement analysis
  • Fig. 18 Artificial organ and bionics market: Product outlook and key takeaways
  • Fig. 19 Artificial kidney market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Artificial heart estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Artificial liver market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Artificial lungs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Artificial pancreas market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Artificial bionics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Cochlear implant market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Exoskeleton market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Bionic limbs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Vision limbs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Brain bionics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Artificial organ and bionics market: Technology movement analysis
  • Fig. 31 Artificial organ and bionics market: Technology outlook and key takeaways
  • Fig. 32 Mechanical market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Electronic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Global artificial organ and bionics market: Regional movement analysis
  • Fig. 35 Global artificial organ and bionics market: Regional outlook and key takeaways
  • Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-147-4

Artificial Organs And Bionics Market Growth & Trends:

The global artificial organs and bionics market size is expected to reach USD 70.09 billion by the year 2030, expanding at a compound annual growth rate (CAGR) of 9.3% during the forecast period, according to a new report by Grand View Research, Inc.. The increasing prevalence of organ failure has resulted in a massive increase in using human-made organs and bionics devices. The rising demand for donors to transplant kidneys, hearts, lungs, livers, and pancreas is a major factor boosting the market growth. Moreover, many biotechnology and medical device companies have concentrated on developing 3D printed bionic. These devices use myoelectric technology and sensory electric technology that enable the mobility of synthetic human body parts.

The COVID-19 pandemic had a detrimental effect on the artificial organ and bionics market. Patients with impairments and organ failures faced additional challenges due to the pandemic. Due to social distancing, many medical facilities were limited to non-elective procedures and surgeries and instead offered patients with impairments video conferencing to conquer market growth limitations. Moreover, there are treatment limitations that have hampered the growth of the market.

An increasing number of product launches and speedy FDA approval of these devices are bridging the shortage of donors. Rising R&D in synthetic human body parts is also boosting artificial organ and bionics market growth. For instance, on March 31, 2022, Edwards Lifesciences confirmed that the FDA certified the MITRIS RESILIA valve (a tissue valve replacement) that is specifically designed for the mitral position of the heart. Thus, with increasing healthcare expenditure and speedy FDA approval of synthetic human body parts, the market is expected to see robust growth during the forecast period.

Artificial Organs And Bionics Market Report Highlights:

  • The artificial organs segment generated the most revenue among all other segments in 2022 due to an escalating number of transplant procedures. The bionics segment is also expected to witness the highest CAGR owing to advancements in products
  • The kidney segment accounted for the largest market share of approximately 57.3% in the year 2022, owing to increasing kidney failures
  • The cochlear implant segment is expected to register the highest growth rate owing to the increasing geriatric population
  • North America was the leading regional segment in 2022 and is expected to maintain its position during the forecast period owing to the presence of advanced healthcare facilities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Technology
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Organ and Bionics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Artificial Organ and Bionics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Artificial Organ and Bionics: Product Estimates & Trend Analysis

  • 4.1. Artificial Organ and Bionics Market: Key Takeaways
  • 4.2. Artificial Organ and Bionics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Artificial Organs
    • 4.3.1. Artificial organs market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Kidney
      • 4.3.2.1. Kidney market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Heart
      • 4.3.3.1. Heart market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Liver
      • 4.3.4.1. Liver market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. Lungs
      • 4.3.5.1. Lungs market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.6. Pancreas
      • 4.3.6.1. Pancreas market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Artificial Bionics
    • 4.4.1. Artificial bionics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Cochlear implant
      • 4.4.2.1. Cochlear implant market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Exoskeleton
      • 4.4.3.1. Exoskeleton market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Bionic limbs
      • 4.4.4.1. Bionic limbs market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.5. Vision limbs
      • 4.4.5.1. Vision limbs market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.6. Brain bionics
      • 4.4.6.1. Brain bionics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Artificial Organ and Bionics: Technology Estimates & Trend Analysis

  • 5.1. Artificial Organ and Bionics Market: Key Takeaways
  • 5.2. Artificial Organ and Bionics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Mechanical
    • 5.3.1. Mechanical market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Electronic
    • 5.4.1. Electronic market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Artificial Organ and Bionics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Artificial Organ and Bionics Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. ABIOMED
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Berlin Heart
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Zimmer Biomet
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Boston Scientific Corporation
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Cochlear Ltd.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Edwards Lifesciences Corporation
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Ekso Bionics
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Medtronic
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Jarvik Heart, Inc
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. SynCardia Systems, LLC
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives